摘要
目的:观察丁咯地尔对大鼠脑缺血再灌注后基质金属蛋白酶-9(MMP-9)与基质金属蛋白酶抑制剂-1(TIMP-1)表达的影响,探讨丁咯地尔的脑保护作用机制。方法:健康SD大鼠108只随机分成假手术组、对照组和丁咯地尔治疗组,每组36只,18只用于检测MMP-9、TIMP-1,18只测量脑组织含水量。大鼠建立脑缺血再灌注损伤模型,缺血时间为1h,假手术组仅在颈外动脉处穿线;对照组制作脑缺血再灌注模型,不作干预;丁咯地尔治疗组于再灌注时经尾静脉给药(赛来乐3ml/kg,每ml含丁咯地尔10mg)。分别于再灌注后1d、2d和3d处死,每个时间点6只大鼠,断头取脑,以干湿重法测量缺血侧脑组织含水量;用免疫组化方法检测MMP-9与TIMP-1阳性细胞的表达情况。结果:在各时间点丁咯地尔治疗组脑组织含水量低于对照组,丁咯地尔治疗组MMP-9细胞阳性率低于对照组,而TIMP-1细胞阳性率仅在再灌注后第3d时高于对照组(P<0.05)。结论:丁咯地尔可能通过调节MMP-9/TIMP-1表达,发挥抗脑水肿作用。
Aim： To investigate the effect of buflomedil on the expression of MMP-9 and TIMP-1 after cerebral isehemia/reperfusion （I/R） injury in rats; Methods： A total of 108 healthy ,male SD rats were randomly divided into sham-operation group, operation group and buflomedil treatment group. Rat transient cerebral ischemic injury model was established with suture emboli method. Six rats were sacrificed at 1 d, 2 d and 3 d, respectively after reperfusion. The brain water content was examined. The expression of MMP-9 and TiMP-1 was detected using immunohistochemical method. Results： The brain water content of buflomedil treatment group was lower than that of the control group. The number of the activated MMP- 9 immunoreactive cells of buflomedil treatment group was lower than that of the control group at 3 time points. The number of the activated TIMP-1 immunoreactive cells of buflomedil treatment group was higher than that of the control group at 3 d after reperfusion, P 〈 0. 05. Conclusion ： Buflomedil has the function against cerebral edema by accommodating MMP-9/TIMP-1.
出处
《郑州大学学报（医学版）》
CAS
北大核心
2007年第1期154-156,共3页
Journal of Zhengzhou University(Medical Sciences)
